The National Institutes of Health (NIH) today announced a pilot effort to significantly
shorten its peer reviews of research grant applications — so scientists
can get on with their research sooner, to the public’s benefit. This pilot rose
from a growing concern that the current grant review process takes too long and
is hindering the careers of promising researchers and the advancement of science
and health.
The pilot will help one of the most promising but vulnerable groups of researchers:
new investigators applying for their first major NIH grant, an R01 grant. R01
grants totaling about $10 billion support many of the best biomedical researchers
at universities and medical centers across the country.
"This pilot illustrates our efforts for optimizing all facets of the research
review and funding process across NIH. I am particularly pleased that the pilot
phase will be focused on new investigators who are the most vulnerable in times
of budgetary constraints and often do not have the resources to withstand long
review cycles," said NIH Director, Elias Zerhouni, M.D. "Shortened review cycles
will benefit researchers and scientific institutions nationwide — and the
public awaiting medical advances."
The new director of the Center for Scientific Review, Toni Scarpa, M.D., Ph.D.,
added, “The scientific world moves fast, and we must keep up with it. We plan
to use new electronic and management tools while preserving the rigor and fairness
of NIH peer review, so we can identify the most promising medical research more
rapidly. Our goal is to reduce the grant review process by half.”
NIH’s Center for Scientific Review (CSR) will initiate the pilot in February
in 40 of its scientific review panels, offering quicker reviews to new investigators
who need to resubmit revised applications for their first R01 grant. This shortened
process and delayed resubmission deadlines will allow researchers able to readily
address reviewer concerns to revise and resubmit their applications for the very
next review cycle, or more than four months earlier than before.
CSR’s process currently takes six months and involves over 15,000 outside scientific
experts. Their resulting evaluations are then sent to the NIH Institutes and
Centers that fund grants for a second review, which usually takes three additional
months. Outside experts on their advisory councils make final recommendations
on which proposals may best address NIH goals and public health needs — to
advance medical knowledge, dietary and life-style preventive measures, vaccines,
therapies and cures. The individual Institute and Center Directors make their
final funding decisions based on the assessments and recommendations that come
out of the two-tiered review process.
The pilot program was devised by CSR and a Trans-NIH Committee to Shorten the
Review Cycle. This committee included representatives from the NIH Institutes/Centers
and the Office of Extramural Research. The plan for the pilot was accepted by
NIH’s Extramural Activities Working Group, which represents all the Institutes
and Centers, at the end of October and was presented to a joint meeting of the
NIH Review Policy Committee and the NIH Extramural Program Management Committee
this month.